Clinical Trial Update: Study of Chiauranib in Patients With Advanced Hepatocellular Carcinoma [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial update for Chiauranib in advanced hepatocellular carcinoma has completed recruitment.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Chiauranib (Chiauranib)

Snippet

Sponsor: Chipscreen Biosciences, Ltd. | Conditions: Hepatocellular Carcinoma | Phase 1, Phase 2 | Status: COMPLETED